G. Laissa Ouedraogo

Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR Boost

P. Earl, B. Moss, N. Sardesai, 2017, The Journal of infectious diseases.